A, M., S, K., C, M., T, F., CV, W., I, F., . . . Y, N. (2023). Study protocol: Combined N-of-1 trials to assess open-label placebo treatment for antidepressant discontinuation symptoms [FAB-study]. BMC psychiatry, 23(1), 749. https://doi.org/10.1186/s12888-023-05184-y
Chicago Style (17th ed.) CitationA, Müller, Konigorski S, Meißner C, Fadai T, Warren CV, Falkenberg I, Kircher T, and Nestoriuc Y. "Study Protocol: Combined N-of-1 Trials to Assess Open-label Placebo Treatment for Antidepressant Discontinuation Symptoms [FAB-study]." BMC Psychiatry 23, no. 1 (2023): 749. https://doi.org/10.1186/s12888-023-05184-y.
MLA (9th ed.) CitationA, Müller, et al. "Study Protocol: Combined N-of-1 Trials to Assess Open-label Placebo Treatment for Antidepressant Discontinuation Symptoms [FAB-study]." BMC Psychiatry, vol. 23, no. 1, 2023, p. 749, https://doi.org/10.1186/s12888-023-05184-y.